| 24/284 |
Carers - Special Leave Policy |
| 24/283 |
65-Week Wait |
| 24/282 |
Waiting Times |
| 24/281 |
Agency Nurse Usage & Spend |
| 24/280 |
Metastatic Renal Cell Carcinoma |
| 24/279 |
Haemophilia B and Von Willebrand Disease |
| 24/276 |
Board of Directors: Members from January 2008 - April 2024 |
| 24/275 |
Treatment of Dermatological Conditions |
| 24/274 |
Virtual Wards & Remote Monitoring Technology |
| 24/273 |
Psychiatric Facilities Data |
| 24/272 |
Physician Associates, Junior Doctors, Anaesthesia Associates & Anaesthetists |
| 24/271 |
Private Maternity Services |
| 24/270 |
Cancelled Operations 2022 - 2024 |
| 24/269 |
Discharge Policy |
| 24/268 |
CAFM (Computer-aided Facility Management) |
| 24/267 |
Vacancies & Recruitment FY 2024 - 2025 and Employer Branding |
| 24/266 |
New Biologic & Targeted Medications within Dermatology & Respiratory Medicine |
| 24/265 |
Overseas Patients 2019 - 2024 |
| 24/264 |
Long Covid Services |
| 24/263 |
Reported Incidents of Racism & Racist Abuse 31.01.2014 - 31.01.2024 |
